Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in Men | NEJM
A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant.
A man with prostate cancer who was receiving androgen blockade had a substantial reduction in the frequency of hot flashes with the use of fezolinetant.
This brief provides key data on socioeconomic characteristics and health coverage among children of immigrants based on KFF analysis of the American Community Survey data.…
Prevention of drug-resistant tuberculosis is a global health priority. However, trials evaluating the effectiveness of treating Mycobacterium tuberculosis infection among contacts of persons with d…
A 35-year-old woman was admitted at 8 weeks postpartum because of shortness of breath and edema in the legs. Proteinuria had developed at the end…
Information on the MMA’s award-winning journal, Minnesota Medicine.
In 2024, ACA enrollment (including Marketplace, Medicaid expansion, and BHP) reached 44 million, or 16.4% of the nonelderly U.S. population. From 2020-2024, enrollment in ACA…
Medical students are faced with a dilemma: for them to learn, enough people have to get sick, with varied and sometimes terrible illnesses. In order…
Read about nocturnal cardiac arrhythmias, spontaneous breathing trial protocols, and indeterminate lung nodules diagnosis.
If sex-based differences in risk result from biased care rather than biology, enshrining the associations in clinical algorithms may be inequitable and unlawful. How can…
Exposure to residential greenness is associated with decreased risk for asthma in infants with severe bronchiolitis.
If the Court rules in favor of Braidwood, private health insurers would no longer be required to cover, without cost sharing, certain preventive services recommended…